IMV Inc.

  • Home
  • About Us
    • Overview
    • Management Team
    • Board of Directors
  • Careers
    • Overview
    • Life at IMV
  • The DPX™ Platform
    • Overview
    • Scientific Publications & Posters
  • Clinical Pipeline
    • Overview
    • Maveropepimut-S
    • DPX-RSV
    • DPX-COVID-19
    • Clinical Trials
  • News & Events
    • Press Releases
    • Events
    • Email Alerts
  • Investors
    • Overview
    • Press Releases
    • Events, Webcasts & Presentations
    • Financial Info
    • Stock Data
    • Filings
    • Governance
    • Contact Us
    • FAQ
  • Contact
    • Get in Touch
    • Safety & Respect

Press Releases

News & Events

News & Events

  • Press Releases
  • Events
  • Email Alerts
Sep 15, 2022 7:45am EDT

IMV Inc. Announces Strategic Reorganization

Sep 01, 2022 7:05am EDT

IMV Inc. to Present at Two Investor Conferences in September

Aug 11, 2022 7:05am EDT

IMV Inc. Announces Second Quarter 2022 Financial and Operational Results

Aug 05, 2022 7:05am EDT

IMV Re-Establishes Its At-the-Market Facility Under Renewed Base Shelf Prospectus

Aug 04, 2022 7:05am EDT

IMV Inc. to Announce Second Quarter 2022 Results and Host a Conference Call and Webcast on August 11, 2022

Jul 08, 2022 4:05pm EDT

IMV Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency

Jun 30, 2022 7:05am EDT

IMV Announces Annual and Special Meeting of Shareholders Voting Results

Jun 22, 2022 7:05am EDT

IMV Strengthens Its Financial Position With the $US10 Million Drawdown From Its Existing Long-Term Debt Facility

May 17, 2022 8:05am EDT

IMV Inc. to Present at the H.C. Wainwright Global Investment Conference

May 13, 2022 7:05am EDT

IMV Inc. Announces First Quarter 2022 Financial and Operational Results

RSS
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • ...42
  • Next
IMV Inc.
About Us Careers The DPX™ Platform Clinical Pipeline News & Events Investors Contact
Twitter LinkedIn Youtube
© 2023 IMV Inc. All Rights Reserved.
Privacy Policy Terms of Use Sitemap